1
Back
Transplantation and Cellular Therapy cover

Transplantation and Cellular Therapy

IF4.4
Papers2066
Citations4360
Journal Papers 2075
Publication Date
delete
Haploidentical versus HLA-Matched Unrelated Donors for Hematopoietic Cell Transplantation in Acute Leukemia: A Multicenter Observational Study in a Developing Country Facilitated by Collaboration between the CIBMTR and the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO)
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-20
delete0
PREAI
deleteMariana Nassif Kerbauy; Leonardo Javier Arcuri; Vergilio Antonio Rensi Colturato; Mair Pedro Souza; Iago Colturato; Phillip Scheinberg; George Mauricio Navarro Barros; Maria Cristina Martins de Almeida Macedo; Vaneuza Araújo Moreira Funke; Andreza Alice Feitosa Ribeiro; Decio Lerner; Victor Gottardello Zecchin; Marcos Paulo Colella; Marcos Roberto Pedron Oltramari; Yana Augusta Novis Zogbi; Liane Esteves Daudt; Rodolfo Soares; Fernando Barroso Duarte; Adriana Seber; Jayr Schmidt Filho
deleteShare
deleteSave
Cytomegalovirus After Autologous Hematopoietic Cell Transplantation: Impact on Outcome and A Personalized Risk-adapted Prevention Strategy
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-20
delete0
deleteOAAI
deleteAlicja Sadowska-Klasa; Hu Xie; Leona A. Holmberg; Alpana Waghmare; Wendy M. Leisenring; Michael J. Boeckh
deleteShare
deleteSave
Association of a Digital Clinical Decision Support Platform With Early Outcomes After Pediatric Allogeneic Hematopoietic Cell Transplantation: A Three-Era Guideline Implementation Cohort Study
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-19
delete0
PREAI
deleteKanayo Collins Nwankwo; Elizabeth Klein; Eric Leroux; Binni Kunvarjee; Jaap-Jan Boelens; Maria I. Cancio
deleteShare
deleteSave
Reduced Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation with Once Daily Intravenous Busulfan for Relapsed/Refractory Lymphoma – a Phase II Study
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-19
delete0
PREAI
deleteCarl Shultz; Shreyas Shirodkar; Chelby Wakefield; Steven Rollins; Sijin Wen; Kelly Ross; Michael Craig; Aaron Cumpston; Mehdi Hamadani; Abraham S. Kanate; Lauren Veltri
deleteShare
deleteSave
Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017–2022)
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-18
delete0
deleteOAAI
deleteSimo Du; Jiahao Peng; Tiantian Zhang; Yuqing Wang; Xiaoyi Zhang; Stepan M. Esagian; Shiwei Han; Yating Wang; Shuai Wang; Mary Lee-Wong; Victor Chang MD; R. AlejandroSica
deleteShare
deleteSave
Evaluating day +90 donor chimerism as a prognostic marker of clinical outcomes among allogeneic hematopoietic cell transplant recipients who received myeloablative conditioning
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-18
delete0
PREAI
deleteSara Jubas; Kieran Collins; Kendall Obara; Hsuan-Hui Liu; Ryan M. Kemper; Alexandra L.W. Kelley; Arushi Goel; Tyler C. Dunlap; Jing Zhu; Riley M. Randolph; Jonathan R. Ptachcinski; Morgan E. Bizzell; Paul M. Armistead; J. Ryan Shaw; Anson E. Snow; Daniel J. Crona
deleteShare
deleteSave
Clinical trials in graft-versus-host disease: changes in study characteristics, investigated drugs, and endpoints over time
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-18
delete0
deleteOAAI
deletePhilipp Melhorn; Nina Dominik; Lina Zoe Rüsing; Julia Cserna; Hanna A Knaus; Axel Schulenburg; Margit Mitterbauer; Hildegard T Greinix; Werner Rabitsch
deleteShare
deleteSave
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-17
delete0
PREAI
deleteNeela Easton; Mia Andreoli; Herman van Besien; Caitlin Gribbin; Michelle Pasciolla; Anna Alperovich; Mateo Mejia Saldarriaga; Barbara Ma; Nora Chokr; Amer Assal; Joshua Fein; Sebastian Mayer; Alexandra Gomez Arteaga; Daniel Choi; Tsiporah Shore; Christopher S. Hackett; Juliet Barker; Samuel Yamshon
deleteShare
deleteSave
Risk factors and outcomes of Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation for hematological malignancy: A 10-year cohort study
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-17
delete0
PREAI
deleteQiusha Huang; Haoyue Cui; Xiaolu Zhu; Yun He; Haixia Fu; Yao Chen; Yuhong Chen; Chenhua Yan; Yuanyuan Zhang; Yifei Cheng; Fengrong Wang; Tingting Han; Yuqian Sun; Xiaodong Mo; Yu Wang; Yingjun Chang; Xiangyu Zhao; Lanping Xu; Xiaojun Huang; Xiaohui Zhang
deleteShare
deleteSave
Dose, Interval, and Context: Interpreting SOS/VOD Risk after Inotuzumab before Second Allogeneic Transplantation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-17
delete0
PREAI
deleteCurtis Marcoux; Partow Kebriaei
deleteShare
deleteSave
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-16
delete0
PREAI
deleteAnnemarie Mohring; Katja Sockel; Christian Thiede; Jan Schröder; Daniel Wolff; Marina Kadantsev; Marek Werth; Markus Schneider; Tabea Globuschuetz; Georg Nikolaus Franke; Sebastian Klein; Joachim Göthert; Cort Hendrik Claassen; Gesine Bug; H. Christian Reinhardt; Anna Hecht-So; Katharina S. Götze; Sara Floßdorf; Wolfgang Bethge; Martin Bornhäuser
deleteShare
deleteSave
The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic Transplantation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-16
delete0
PREAI
deleteDat Ngo; Jose Tinajero; Karamjeet Sandhu; Idoroenyi Amanam; Salman Otoukesh; Shukaib Arslan; Sunmin Park; Haris Ali; Badri Modi; Ryotaro Nakamura; Amandeep Salhotra
deleteShare
deleteSave
A Comparative Analysis of Skin Responses per 2014 NIH Response Criteria and Modified 2025 NIH Skin Task Force Response Criteria in Patients with Sclerotic Chronic Graft-Versus-Host Disease
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-14
delete0
PREAI
deleteAmila Kapetanovic; Rania Hishmeh; Anita Stokes; Edward W. Cowen; Steven Z. Pavletic; Najla El Jurdi
deleteShare
deleteSave
Nationwide Centralized Manufacturing and Fresh Distribution of TCRαβ/CD19-DepletedGrafts: A Real-World French Experience
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-13
delete0
PREAI
deleteUgo Chartral; Mony Fahd; Emma Gasperment; Charlotte Calvo; Martin Castelle; Elvira Duchesne; Aurélie Gabrion; Cécile Roudaut; Chloé Mollet; Brigitte Ternaux; Maxime Bouabdelli; Eden Schwartz; François Lefrère; Despina Moshous; Vincent Barlogis; Anne Charlotte Teyssier; Boris Calmels; Clemence Demerle; Anne-Line Chateau; Nimrod Buchbinder
deleteShare
deleteSave
Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood Transplantation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-13
delete0
PREAI
deleteNaoki Okada; Hiroyuki Muranushi; Junya Kanda; Tadakazu Kondo; Yasuyuki Arai; Takeshi Maeda; Yasuko Miyahara; Haruka Okamoto; Hiroki Amagase; Akihito Yonezawa; Toshiyuki Kitano; Kazuhiro Yago; Kazunori Imada; Tomoharu Takeoka; Ikue Okamura-Shiki; Takashi Ikeda; Kouhei Yamashita; Akifumi Takaori-Kondo
deleteShare
deleteSave
Randomized trial of two fractionation schedules of myeloablative busulfan with fludarabine and cladribine in AML or MDS
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-12
delete0
PREAI
deleteUday R. Popat; Konstantinos Lontos; Roland Bassett; Jitesh Kawedia; Ben C. Valdez; Alison M. Gulbis; Amin M. Alousi; Gheath Al-Atrash; Qaiser Bashir; Chitra M. Hosing; Jin S. Im; Partow Kebriaei; Issa Khouri; David Marin; Rohtesh S. Mehta; Yago Nieto; Betul Oran; Amanda Olson; Muzaffar H. Qazilbash; Jeremy Ramdial
deleteShare
deleteSave
T-Cell Lymphoma Associated with CAR-T Cell Therapy: A Bayesian Disproportionality Analysis of a National Database
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-11
delete0
deleteOAAI
deleteConnor Frey
deleteShare
deleteSave
Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective Analysis
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-10
delete0
deleteOAAI
deleteAlexandre Chevalier; Baptiste Bonneau; Lea Grote-Levi; Nora Möhn; Paola Cinque; Jeremy D. Rubinstein; Rebecca Wicklein; Thomas Pfeiffer; Bilal Omer; Maximilian Steinhardt; Jean-Jacques Tudesq; Nathalie Testard; Patrice Chevallier; Raphael Bernard-Valnet; Marion Le Maréchal; Gaia Catalano; Béatrice Pignolet; Agnès Sommet; Britta Eiz-Vesper; Patrizia Comoli
deleteShare
deleteSave
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapies.
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-10
delete0
PREAI
deleteAgrima Mian; Rafaella Litvin; Danai Dima; Betty K. Hamilton; Allison Winter; Jack Khouri; Louis Williams; Shahzad Raza; Deepa Jagadeesh; Aaron T. Gerds; Robert M. Dean; Ronald M. Sobecks; Faiz Anwer; Matt E. Kalaycio; Claudio G. Brunstein; Craig S. Sauter; Marcelo Pasquini; Brian T. Hill; Paolo F. Caimi
deleteShare
deleteSave
Lnc-BRMS1L-4 and ZEB1-AS1 expression in acute lymphoblastic leukemia and its correlation with acute graft-versus-host disease after hematopoietic stem cell transplantation
deleteTransplantation and Cellular Therapy
IF4.4
delete2026-06-09
delete0
PREAI
deleteMahdiyar Iravani Saadi; Fakhroddin Hosseini; Nasrin Noshadi; Mani Ramzi; Zahed karimi; Maryam Ahmadyan; Ramin Yaghobi
deleteShare
deleteSave